53. Sjogren syndrome Clinical trials / Disease details
Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2007-003537-16-NL (EUCTR) | 04/09/2008 | 09/08/2007 | Estetrol Therapy in Sjogren's Syndrome: An Open Proof of Concept Study | Estetrol Therapy in Sjogren's Syndrome: An Open Proof of Concept Study | Primary Sjogren's Syndrome MedDRA version: 9.1;Level: LLT;Classification code 10040767;Term: Sjogren's syndrome | Product Name: estetrol Product Code: E4 | Erasmus MC | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: no | Netherlands |